Disrupted circadian rhythms are linked to higher PD-1/PD-L1 levels and T cell exhaustion, suggesting that circadian regulation of immune checkpoints may impact cancer progression and the response to therapy, supporting the potential of chrono-immunotherapy. This evidence concerns the gene PDCD1 and cancer.